1060 related articles for article (PubMed ID: 34111274)
21. Efficacy of the combination of baricitinib, remdesivir, and dexamethasone in hypoxic adults with COVID-19: A retrospective study.
Yasuda Y; Hirayama Y; Uemasu K; Arasawa S; Iwashima D; Takahashi KI
Respir Med Res; 2022 May; 81():100903. PubMed ID: 35316675
[TBL] [Abstract][Full Text] [Related]
22. Real-life use of remdesivir in hospitalized patients with COVID-19.
Garcia-Vidal C; Meira F; Cózar-Llistó A; Dueñas G; Puerta-Alcalde P; Garcia-Pouton N; Chumbita M; Cardozo C; Hernandez-Meneses M; Alonso-Navarro R; Rico V; Agüero D; Bodro M; Morata L; Jordan C; Lopera C; Ambrosioni J; Segui F; Grafia N; Castro P; García F; Mensa J; Martínez JA; Sanjuan G; Soriano A;
Rev Esp Quimioter; 2021 Apr; 34(2):136-140. PubMed ID: 33675220
[TBL] [Abstract][Full Text] [Related]
23. Remdesivir and systemic corticosteroids for the treatment of COVID-19: A Bayesian re-analysis.
Lee TC; McDonald EG; Butler-Laporte G; Harrison LB; Cheng MP; Brophy JM
Int J Infect Dis; 2021 Mar; 104():671-676. PubMed ID: 33540128
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors for poor outcomes in patients with severe COVID-19 treated with remdesivir plus dexamethasone in Taiwan.
Lai YH; Lee YC; Chen IR; Lin SN; Chang YL; Lu CC; Wu PF; Lin YT
J Microbiol Immunol Infect; 2023 Dec; 56(6):1207-1213. PubMed ID: 37696685
[TBL] [Abstract][Full Text] [Related]
25. Use of remdesivir in patients with COVID-19: a systematic review and meta-analysis.
Tanni SE; Silvinato A; Floriano I; Bacha HA; Barbosa AN; Bernardo WM
J Bras Pneumol; 2022; 48(1):e20210393. PubMed ID: 35137874
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the safety profile and therapeutic efficacy of remdesivir in children with SARS-CoV-2 infection - a single-center, retrospective, cohort study.
Kautsch K; Wiśniowska J; Friedman-Gruszczyńska J; Buda P
Eur J Pediatr; 2024 Feb; 183(2):591-598. PubMed ID: 37864601
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of remdesivir-based therapy for moderate COVID-19: comparison of Omicron and other variant phases.
Suzuki A; Fukumitsu K; Fukihara J; Katano T; Kako H; Maeda Y; Ishii M; Niimi A; Imaizumi K; Yamaguchi E
J Chemother; 2024 Apr; 36(2):127-132. PubMed ID: 38044564
[TBL] [Abstract][Full Text] [Related]
28. USA stockpiling of remdesivir: How should the world respond?
Dawoud D; Chalkidou K; Sullivan R; Ruiz FJ; Adler A
J Comp Eff Res; 2020 Dec; 9(18):1243-1246. PubMed ID: 33274643
[TBL] [Abstract][Full Text] [Related]
29. A shorter symptom onset to remdesivir treatment (SORT) interval is associated with a lower mortality in moderate-to-severe COVID-19: A real-world analysis.
Mehta RM; Bansal S; Bysani S; Kalpakam H
Int J Infect Dis; 2021 May; 106():71-77. PubMed ID: 33647517
[TBL] [Abstract][Full Text] [Related]
30. Remdesivir, Renal Function and Short-Term Clinical Outcomes in Elderly COVID-19 Pneumonia Patients: A Single-Centre Study.
Biancalana E; Chiriacò M; Sciarrone P; Mengozzi A; Mechelli S; Taddei S; Solini A
Clin Interv Aging; 2021; 16():1037-1046. PubMed ID: 34113086
[TBL] [Abstract][Full Text] [Related]
31. RETRACTED: Remdesivir Efficacy in COVID-19 Treatment: A Randomized Controlled Trial.
Abd-Elsalam S; Salama M; Soliman S; Naguib AM; Ibrahim IS; Torky M; El Ghafar MSA; Abdul-Baki EAM; Elhendawy M
Am J Trop Med Hyg; 2021 Sep; 106(3):886-890. PubMed ID: 34649223
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of remdesivir in hospitalized Covid-19 patients: Systematic review and meta-analysis including network meta-analysis.
Elsawah HK; Elsokary MA; Abdallah MS; ElShafie AH
Rev Med Virol; 2021 Jul; 31(4):e2187. PubMed ID: 33128490
[TBL] [Abstract][Full Text] [Related]
33. Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial.
Ali K; Azher T; Baqi M; Binnie A; Borgia S; Carrier FM; Cavayas YA; Chagnon N; Cheng MP; Conly J; Costiniuk C; Daley P; Daneman N; Douglas J; Downey C; Duan E; Duceppe E; Durand M; English S; Farjou G; Fera E; Fontela P; Fowler R; Fralick M; Geagea A; Grant J; Harrison LB; Havey T; Hoang H; Kelly LE; Keynan Y; Khwaja K; Klein G; Klein M; Kolan C; Kronfli N; Lamontagne F; Lau R; Fralick M; Lee TC; Lee N; Lim R; Longo S; Lostun A; MacIntyre E; Malhamé I; Mangof K; McGuinty M; Mergler S; Munan MP; Murthy S; O'Neil C; Ovakim D; Papenburg J; Parhar K; Parvathy SN; Patel C; Perez-Patrigeon S; Pinto R; Rajakumaran S; Rishu A; Roba-Oshin M; Rushton M; Saleem M; Salvadori M; Scherr K; Schwartz K; Semret M; Silverman M; Singh A; Sligl W; Smith S; Somayaji R; Tan DHS; Tobin S; Todd M; Tran TV; Tremblay A; Tsang J; Turgeon A; Vakil E; Weatherald J; Yansouni C; Zarychanski R; ;
CMAJ; 2022 Feb; 194(7):E242-E251. PubMed ID: 35045989
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors of 30-day mortality in patients with COVID-19 pneumonia under standard remdesivir and dexamethasone treatment.
Choi YJ; Song JY; Hyun H; Nham E; Yoon JG; Seong H; Noh JY; Cheong HJ; Kim WJ
Medicine (Baltimore); 2022 Sep; 101(38):e30474. PubMed ID: 36197235
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis.
Piscoya A; Ng-Sueng LF; Parra Del Riego A; Cerna-Viacava R; Pasupuleti V; Roman YM; Thota P; White CM; Hernandez AV
PLoS One; 2020; 15(12):e0243705. PubMed ID: 33301514
[TBL] [Abstract][Full Text] [Related]
36. Remdesivir treatment in hospitalized patients affected by COVID-19 pneumonia: A case-control study.
Boglione L; Dodaro V; Meli G; Rostagno R; Poletti F; Moglia R; Bianchi B; Esposito M; Borrè S
J Med Virol; 2022 Aug; 94(8):3653-3660. PubMed ID: 35411627
[TBL] [Abstract][Full Text] [Related]
37. A Case Report for Severe COVID-19 in a 9-Year-Old Child Treated with Remdesivir and Dexamethasone.
Jo YH; Hwang Y; Choi SH
J Korean Med Sci; 2021 Jul; 36(29):e203. PubMed ID: 34313036
[TBL] [Abstract][Full Text] [Related]
38. Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial.
Potter GE; Bonnett T; Rubenstein K; Lindholm DA; Rapaka RR; Doernberg SB; Lye DC; Mularski RA; Hynes NA; Kline S; Paules CI; Wolfe CR; Frank MG; Rouphael NG; Deye GA; Sweeney DA; Colombo RE; Davey RT; Mehta AK; Whitaker JA; Castro JG; Amin AN; Colombo CJ; Levine CB; Jain MK; Maves RC; Marconi VC; Grossberg R; Hozayen S; Burgess TH; Atmar RL; Ganesan A; Gomez CA; Benson CA; Lopez de Castilla D; Ahuja N; George SL; Nayak SU; Cohen SH; Lalani T; Short WR; Erdmann N; Tomashek KM; Tebas P
Ann Intern Med; 2022 Dec; 175(12):1716-1727. PubMed ID: 36442063
[TBL] [Abstract][Full Text] [Related]
39. Patterns of corticosteroid use among remdesivir and matched patients and associated clinical outcomes in hospitalized COVID-19 patients.
Papic I; Bistrovic P; Keres T; Ortner Hadziabdic M; Lucijanic M
Expert Opin Pharmacother; 2024 Feb; 25(2):215-222. PubMed ID: 38362773
[TBL] [Abstract][Full Text] [Related]
40. Cost utility analysis of Remdesivir and Dexamethasone treatment for hospitalised COVID-19 patients - a hypothetical study.
Carta A; Conversano C
BMC Health Serv Res; 2021 Sep; 21(1):986. PubMed ID: 34537034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
